Loading: 100%
BIO-TECHNE Corp logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 1,800 (as per Q3 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker TECHno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1790100110120130
datesClosing price (adj.)
13.10.2017121.65
11.10.2017123.44
04.10.2017122.45
27.09.2017121.21
20.09.2017121.25
13.09.2017122.83
06.09.2017121.66
30.08.2017120.64
23.08.2017119.07
16.08.2017118.30
09.08.2017114.13
02.08.2017115.11
26.07.2017116.91
19.07.2017116.63
12.07.2017115.96
05.07.2017115.94
27.06.2017117.27
20.06.2017112.59
13.06.2017111.06
06.06.2017113.61
30.05.2017111.17
23.05.2017110.55
16.05.2017110.81
09.05.2017109.93
02.05.2017110.50
25.04.2017103.79
18.04.2017100.71
11.04.201799.86
04.04.201799.77
28.03.201799.45
21.03.2017101.72
14.03.2017106.23
07.03.2017106.10
28.02.2017105.72
21.02.2017104.82
14.02.2017103.62
07.02.2017100.31
31.01.2017100.87
24.01.201797.11
17.01.201798.21
10.01.2017103.11
03.01.2017101.73
27.12.2016103.14
19.12.2016103.33
12.12.2016104.19
05.12.2016105.44
28.11.2016105.05
21.11.2016103.72
14.11.2016105.63
07.11.201699.61
31.10.2016102.78
24.10.2016104.29
17.10.2016103.86
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
121.65n/a
Market Capitalisation
in million USD
4,542n/a
Enterprise Value
in million USD
4,590n/a
Common Shares Outstanding
as per Mar 31, 2017
37,333,015n/a
Preferred Shares Outstanding
as per Mar 31, 2017
n/a
Average Basic Shares Outstanding
TTM
37,282,750n/a
Average Diluted Shares Outstanding
TTM
37,461,750n/a
Index Membership
n/a
Business Summary
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 114n/a
Receivables 66n/a
Total Current Assets 258n/a
PP&E 134n/a
Total Assets 1,133n/a
Accounts Payable 10n/a
Current Debt 0n/a
Total Current Liabilities 36n/a
Long-Term Debt 163n/a
Total Liabilities 277n/a
Total Equity 856n/a
Cash Flow
Depreciation & Amortisation 43n/a
Change in Working Capital -15n/a
Operating Cash Flow 144n/a
Net Change in PP&E and Intangibles -17n/a
Investing Cash Flow -108n/a
Dividends Paid -48n/a
Financing Cash Flow -23n/a
Total Change in Cash 10n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.19n/a
Other Ratios
Current Ratio 721.2%n/a
Liabilities to Equity Ratio 32.4%n/a
Debt to Assets Ratio 14.4%n/a
Profit & Loss StatementP&L data quality: 35% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
264
269
290
315
311
358
452
499
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-56
-55
-65
-79
-79
-106
-145
-162
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
208
214
225
236
231
251
307
337
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-57
-58
-62
-70
73
-92
-160
-186
Selling, General & Administrative
-34
-33
-36
-42
43
-61
-119
-141
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-24
-25
-26
-28
29
-31
-41
-45
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
151
156
163
166
304
160
147
151
Non-Operating Income (Loss)
-11
-9
-6
-6
-3
-4
6
-4
Interest Expense, net
-8
-4
-4
-3
-3
-3
-2
-2
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-3
-4
-2
-3
0
-1
8
-2
Pretax Income (Loss), Adjusted
140
148
157
160
301
156
153
147
Abnormal Gains (Losses)
0
0
0
3
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
140
148
157
163
301
156
153
147
Income Tax (Expense) Benefit, net
-50
-47
-53
-50
-48
-50
-46
-43
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
90
101
105
114
253
106
106
104
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
90
101
105
114
253
106
106
104
Minority Interest
0
0
0
0
0
0
0
0
Net Income
90
101
105
114
253
106
106
104
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
90
101
105
114
253
106
106
104
Remarks
restated on Aug 29, 2011 n/a
calculated values,
restated on Aug 29, 2012 n/a
calculated values,
restated on Aug 29, 2013 n/a
calculated values,
restated on Aug 29, 2014 n/a
calculated values,
restated on Aug 31, 2015 n/a
calculated values,
restated on Aug 29, 2016 n/a
calculated values,
restated on Aug 29, 2016 n/a
calculated values,
restated on Aug 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 88% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
139
141
269
333
363
111
96
Cash & Cash Equivalents
n/a
94
78
117
164
319
55
64
Short Term Investments
n/a
45
63
152
169
45
56
32
Accounts & Notes Receivable
n/a
31
36
36
38
55
70
93
Accounts Receivable, Net
n/a
31
36
36
38
55
70
93
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
14
45
38
35
39
50
57
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
18
9
4
4
12
18
8
Prepaid Expenses
n/a
1
1
2
2
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
13
6
0
0
10
12
0
Income Taxes Receivable
n/a
2
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
2
2
2
2
3
6
8
Total Current Assets
n/a
201
230
347
410
469
248
254
Property, Plant & Equipment, Net
n/a
97
95
94
109
117
130
132
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
171
132
144
132
4
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
49
160
135
127
272
685
736
Intangible Assets
n/a
2
52
46
41
109
293
303
Goodwill
n/a
25
87
86
84
151
391
431
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
1
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
21
20
1
1
10
0
0
Miscellaneous Long Term Assets
n/a
1
1
2
2
2
2
2
Total Noncurrent Assets
n/a
318
387
373
369
393
815
868
Total Assets
n/a
519
618
719
778
862
1,063
1,122
Liabilities and owners' equity
Payables & Accruals
n/a
13 13243000
13 13404000
17 16817000
18 18115000
14 14284000
22 22019000
31 30803000
Accounts Payable
n/a
5 5232000
5 5207000
6 6291000
6 6236000
10 9652000
13 13443000
21 20653000
Accrued Taxes
n/a
4 3636000
6 5509000
3 3251000
2 2276000
0 496000
2 1972000
2 1779000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
4 4375000
3 2688000
7 7275000
10 9603000
4 4136000
7 6604000
8 8371000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
4 3781000
5 4784000
19 18933000
14 13969000
12 12107000
18 17748000
23 23344000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
3 3380000
5 4717000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
14 14234000
10 9944000
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
4 3781000
5 4784000
5 4699000
4 4025000
12 12107000
14 14368000
19 18627000
Total Current Liabilities
n/a
17 17024000
18 18188000
36 35750000
32 32084000
26 26391000
40 39767000
54 54147000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
-73 -73000000
-92 -91500000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
0 0
13 13360000
9 9132000
8 8473000
41 40835000
104 103657000
105 104654000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
13 13360000
9 9132000
8 8473000
34 33838000
61 61429000
63 62837000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
0 0
0 0
0 0
7 6997000
42 42228000
42 41817000
Total Noncurrent Liabilities
n/a
0 0
13 13360000
9 9132000
8 8473000
41 40835000
31 30657000
13 13154000
Total Liabilities
n/a
17 17024000
32 31548000
45 44882000
41 40557000
67 67226000
70 70424000
67 67301000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
123 122907000
130 129683000
132 132219000
135 135263000
147 147374000
164 163677000
179 179132000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
400 400119000
473 472730000
520 520448000
588 587725000
653 653279000
-714 -713851000
-771 -770553000
Other Equity
n/a
-21 -21234000
-16 -16291000
22 21775000
15 14553000
-5 -5388000
31 30593000
70 70405000
Equity Before Minority Interest
n/a
502 501792000
586 586122000
674 674442000
738 737541000
795 795265000
-520 -519581000
-521 -521016000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
502 501792000
586 586122000
674 674442000
738 737541000
795 795265000
-520 -519581000
-521 -521016000
Total Liabilities & Equity
n/a
519 518816000
618 617670000
719 719324000
778 778098000
862 862491000
-449 -449157000
-454 -453715000
Remarks restated on n/a restated on Aug 29, 2011 n/a restated on Aug 29, 2012 n/a restated on Aug 29, 2013 n/a restated on Aug 29, 2014 n/a restated on Aug 31, 2015 n/a restated on Aug 29, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 38% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
105
110
112
112
113
111
108
104
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
8
8
9
12
12
19
37
43
Non-Cash Items
2
1
6
6
4
8
6
12
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-4
-8
0
-4
-5
-2
-11
-15
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
111
111
127
127
124
137
139
144
Change in Fixed Assets & Intangibles
-7
-5
-4
-6
-22
-14
-20
-17
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
26
-110
22
-15
-9
183
13
1
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
-132
0
0
-109
-420
-91
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
1
0
-1
0
0
-10
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
21
-115
-114
-22
-31
50
-426
-108
Dividends Paid
-28
-38
-40
-41
-43
-45
-47
-48
Cash From (Repayment of) Debt
0
0
0
0
0
0
68
19
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-90
-12
3
-23
-1
8
10
5
Increase in Capital Stock
1
3
5
1
1
8
10
5
Decrease in Capital Stock
-91
-15
-2
-24
-2
0
0
0
Other Financing Activities
0
0
1
0
0
0
1
1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
-118
-50
-36
-64
-44
-37
31
-23
Net Cash Before Disc. Operations and FX
15
-53
-23
41
48
150
-256
13
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
15
-53
-23
41
48
150
-256
13
Effect of Foreign Exchange Rates
-19
-13
7
-1
-1
5
-8
-4
Net Changes in Cash
-4
-66
-16
40
48
155
-264
10
Remarks
restated on Aug 29, 2011 n/a
calculated values,
restated on Aug 29, 2012 n/a
calculated values,
restated on Aug 29, 2013 n/a
calculated values,
restated on Aug 29, 2014 n/a
calculated values,
restated on Aug 31, 2015 n/a
calculated values,
restated on Aug 29, 2016 n/a
calculated values,
restated on Aug 29, 2016 n/a
calculated values,
restated on Aug 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo